Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to 0.8.

  • Bio-Techne's Equity Ratio rose 241.8% to 0.8 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.8, marking a year-over-year increase of 241.8%. This contributed to the annual value of 0.75 for FY2025, which is 195.86% down from last year.
  • As of Q4 2025, Bio-Techne's Equity Ratio stood at 0.8, which was up 241.8% from 0.78 recorded in Q3 2025.
  • Bio-Techne's 5-year Equity Ratio high stood at 0.8 for Q4 2025, and its period low was 0.69 during Q2 2021.
  • Over the past 5 years, Bio-Techne's median Equity Ratio value was 0.75 (recorded in 2022), while the average stood at 0.75.
  • In the last 5 years, Bio-Techne's Equity Ratio soared by 1495.41% in 2021 and then tumbled by 698.88% in 2023.
  • Bio-Techne's Equity Ratio (Quarter) stood at 0.74 in 2021, then grew by 4.63% to 0.77 in 2022, then fell by 6.99% to 0.72 in 2023, then rose by 8.24% to 0.78 in 2024, then increased by 2.42% to 0.8 in 2025.
  • Its Equity Ratio stands at 0.8 for Q4 2025, versus 0.78 for Q3 2025 and 0.75 for Q2 2025.